1-6 of 6
Morihiro Higashi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Absolute Count of Lymphocytes Is a Strong Predictive Factor for Relapse/Regrowth Events and Outcomes in Patients with Regressive Methotrexate-Associated Lymphoproliferative Disorders

Michihide Tokuhira, Yuta Kimura, MD, Yuka Tanaka, MD, Yasuyuki Takahashi, MD PhD, Tatsuki Tomikawa, MD PhD, Junichi Watanabe, MD PhD, Tomoe Anan-Nemoto, MD PhD, Morihiko Sagawa, MD PhD, Shuji Momose, MD PhD, Morihiro Higashi, MD PhD, Tabayashi Takayuki, MD PhD, Reiko Nakaseko, MD PhD, Jun-ichi Tamaru, MDPhD, Masahiro Kizaki, MDPhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1589.
https://doi.org/10.1182/blood-2018-99-114382
Published: 2018
Journal Articles

Impact of the Duration of Methotrexate Administration and the Specific HLA Alleles on the Regressive Methotrexate-Induced Lymphoproliferative Disorders

Michihide Tokuhira, MD, Shuntaro Saito, MD, Ayumi Okuyama, MD, Katsuya Suzuki, MD, Morihiro Higashi, MD, Shuju Momose, MD, Takayuki Shimizu, MD, Takehiko Mori, MD PhD, Tomoe Anan-Nemoto, MD, Koichi Amano, MD, Shinichiro Okamoto, MD PhD, Tsutomu Takeuchi, MD, Jun-ichi Tamaru, MDPhD, Masahiro Kizaki, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4024.
https://doi.org/10.1182/blood.V130.Suppl_1.4024.4024
Published: 2017
Journal Articles

CD14-CD15+, Possible Cells Are Potent Myeloid-Derived Suppressor Cells, Which Affect the Pathogenesis of Induction and Regression in Methotrexate-Mediated Lymphoproliferative Disorders

Michihide Tokuhira, MD PhD, Shuntaro Saito, MD, Yuka Tanaka, MD, Yasuyuki Takahashi, MD, Yuta Kimura, MD, Tatsuki Tomikawa, MD, Tomoe Anan, MD, PhD, Shuji Momose, MD PhD, Morihiro Higashi, MD, PhD, Takayuki Shimizu, MD PhD, Takehiko Mori, MD PhD, Takayuki Tabayashi, MD PhD, Reiko Watanabe, MD PhD, Jun-ichi Tamaru, MD, PhD, Shinichiro Okamoto, MD PhD, Masahiro Kizaki, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2946.
https://doi.org/10.1182/blood.V128.22.2946.2946
Published: 2016
Journal Articles

Serum Soluble LR11 Can Predict High FLIPI-2 Score in Follicular Lymphoma.

Takeharu Kawaguchi, MD, Chikako Ohwada, MD, PhD, Naomi Shimizu, MD, PhD, Masahiro Takeuchi, MD, PhD, Emiko Sakaida, M.D., PhD., Yusuke Takeda, M.D., PhD., Shio Sakai, MD, PhD, Shokichi Tsukamoto, MD, Atsuko Yamazaki, MD, Morihiro Higashi, M.D., PhD., Jun-Ichi Tamaru, M.D., PhD., Kotaro Yokote, M.D., PhD., Hideaki Bujo, MD, PhD, Chiaki Nakaseko, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2673.
https://doi.org/10.1182/blood.V120.21.2673.2673
Published: 2012
Journal Articles

LR11 Is a Potential Serum and Histological Biomarker for Intravascular Large B-Cell Lymphoma

Chikako Ohwada, MD, PhD, Takeharu Kawaguchi, MD, Naomi Shimizu, MD, PhD, Masahiro Takeuchi, MD, PhD, Emiko Sakaida, M.D., PhD., Yusuke Takeda, M.D., PhD., Kazuhisa Fujikawa, MD, PhD, Kosei Matsue, MD, PhD, Morihiro Higashi, M.D., PhD., Jun-Ichi Tamaru, M.D., PhD., Kotaro Yokote, M.D., PhD., Hideaki Bujo, MD, PhD, Chiaki Nakaseko, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 5104.
https://doi.org/10.1182/blood.V120.21.5104.5104
Published: 2012
Journal Articles

Serum Soluble LR11 As a Novel Biomarker for B Cell Lymphoma

Takeharu Kawaguchi, M.D., Chikako Ohwada, MD, PhD., Morihiro Higashi, M.D., PhD., Masahiro Takeuchi, MD, PhD, Shio Sakai, M.D., PhD., Yusuke Takeda, M.D., PhD., Naomi Shimizu, MD, PhD, Emiko Sakaida, M.D., PhD., Kohei Takubo, PhD., Hiroyuki Ebinuma, PhD., Isamu Fukamachi, PhD., Jun-Ichi Tamaru, M.D., PhD., Koutaro Yokote, MD, PhD, Hideaki Bujo, MD, PhD, Chiaki Nakaseko, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1581.
https://doi.org/10.1182/blood.V118.21.1581.1581
Published: 2011